Quarterly report · Q1
2269.TEDINET S100RKR4
Period2023-04-01 → 2023-06-30
Filed2023-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥262.7bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥1.06T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥247.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥19.5bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥18.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥19.2bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥74.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.4bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥22.6bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥23.2bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.6bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥69.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥16.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.5bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥16.2bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥1.17T | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥1.14T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.14T | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥409.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥384.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥762.1bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥751.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥725.4bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥84.1bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥63.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥81.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥84.9bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥85.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥5.7bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥36.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥22.5bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥54.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥22.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥41.59 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.39 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.87 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 61.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥151m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥151m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥310m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥218.7bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥218.6bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥147m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥15.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥44.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥44.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3m |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥262.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥262.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥151m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥19.8bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥140m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥140m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥278m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥204.4bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥204.3bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥14.5bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥42.9bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥42.9bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9m |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥247.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥247.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥140m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥18.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Cost of sales | CurrentYTDDuration | 186470000000 | JPY |
| Gross profit | Prior1YTDDuration | 72988000000 | JPY |
| Gross profit | CurrentYTDDuration | 76264000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 54944000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 56766000000 | JPY |
| Operating income | Prior1YTDDuration | 18044000000 | JPY |
| Operating income | CurrentYTDDuration | 19497000000 | JPY |
| Interest income noi | Prior1YTDDuration | 57000000 | JPY |
| Interest income noi | CurrentYTDDuration | 130000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 727000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 678000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 0 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 179000000 | JPY |
| Other noi | Prior1YTDDuration | 294000000 | JPY |
| Other noi | CurrentYTDDuration | 399000000 | JPY |
| Non operating income | Prior1YTDDuration | 1079000000 | JPY |
| Non operating income | CurrentYTDDuration | 1387000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 122000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 94000000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 59000000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 1040000000 | JPY |
| Other noe | Prior1YTDDuration | 527000000 | JPY |
| Other noe | CurrentYTDDuration | 535000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 709000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 1670000000 | JPY |
| Ordinary income | Prior1YTDDuration | 18414000000 | JPY |
| Ordinary income | CurrentYTDDuration | 19214000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 4456000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 1465000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 0 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 714000000 | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | Prior1YTDDuration | 1068000000 | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | CurrentYTDDuration | 2720000000 | JPY |
| Subsidy ei | Prior1YTDDuration | 6000000 | JPY |
| Subsidy ei | CurrentYTDDuration | 532000000 | JPY |
| Other ei | Prior1YTDDuration | 4000000 | JPY |
| Other ei | CurrentYTDDuration | 2000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 5536000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 5434000000 | JPY |
| Loss on abandonment of noncurrent assets el | Prior1YTDDuration | 551000000 | JPY |
| Loss on abandonment of noncurrent assets el | CurrentYTDDuration | 895000000 | JPY |
| Loss on reduction of noncurrent assets el | Prior1YTDDuration | 6000000 | JPY |
| Loss on reduction of noncurrent assets el | CurrentYTDDuration | 532000000 | JPY |
| Loss on sales of stocks of subsidiaries and affiliates el | Prior1YTDDuration | － | JPY |
| Loss on sales of stocks of subsidiaries and affiliates el | CurrentYTDDuration | 501000000 | JPY |
| Other el | Prior1YTDDuration | 235000000 | JPY |
| Other el | CurrentYTDDuration | 89000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 792000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 2019000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 23158000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |